Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)

American Journal of Cardiology

Volumn 111, Issue 5, 2013, Pages 676-683

  De La Torre Hernandez, Jose M ^a   Alfonso, Fernando ^b   Sanchez Recalde, Angel ^c   Jimenez Navarro, Manuel F ^d   Perez De Prado, Armando ^e   Hernandez, Felipe ^f   Abdul Jawad Altisent, Omar ^g   Roura, Gerard ^h   Garcia Camarero, Tamara ^a   Elizaga, Jaime ⁱ   Rivero, Fernando ^j   Gimeno, Federico ^k   Calviño, Ramon ^l   Moreu, Jose ^m   Bosa, Francisco ⁿ   Rumoroso, Jose R ^o   Bullones, Juan A ^p   Gallardo, Arsenio ^q   Fernandez Diaz, Jose A ^r   Ruiz Arroyo, Jose R ^s   Aragon, Victor ^t   Masotti, Monica ^u   more..

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e HOSPITAL DE LEÓN   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^k HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^l Hospital de La Coruña   (Spain)

^m HOSPITAL VIRGEN DE LA SALUD   (Spain)

ⁿ Hospital de Tenerife   (Spain)

^o HOSPITAL DE GALDAKAO   (Spain)

^p HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^q Hospital de Albacete   (Spain)

^r HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^s HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^t Hosp Univ Ciudad de Jaén   (Spain)

^u HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT MAIN CORONARY ARTERY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; PACLITAXEL; REGISTRIES; RETROSPECTIVE STUDIES; SIROLIMUS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873702346     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.11.019     Document Type: Article

References (27)

1. M. Sanmartin, J.A. Baz, I. Lozano, J.M. de la Torre, J.M. Hernandez, P. Bordes, V. Mainar, J. Mauri, and A. Iñiguez One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry Catheter Cardiovasc Interv 69 2007 372 377
2. B. Vaquerizo, T. Lefèvre, O. Darremont, M. Silvestri, Y. Louvard, J.L. Leymarie, P. Garot, H. Routledge, F. de Marco, T. Unterseeh, M. Zwahlen, and M.C. Morice Unprotected left main stenting in the real world: two-year outcomes of the French left main Taxus registry Circulation 119 2009 2349 2356
3. A. Chieffo, V. Magni, A. Latib, F. Maisano, A. Ielasi, M. Montorfano, M. Carlino, C. Godino, M. Ferraro, G. Calori, O. Alfieri, and A.A. Colombo 5-Year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions: the Milan experience JACC Cardiovasc Interv 3 2010 595 601
4. D.W. Park, K.B. Seung, Y.H. Kim, J.Y. Lee, W.J. Kim, S.J. Kang, S.W. Lee, C.W. Lee, S.W. Park, S.C. Yun, H.C. Gwon, M.H. Jeong, Y.S. Jang, H.S. Kim, P.J. Kim, I.W. Seong, H.S. Park, T. Ahn, I.H. Chae, S.J. Tahk, W.S. Chung, and S.J. Park Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry J Am Coll Cardiol 56 2010 117 124
5. Y. Onuma, C. Girasis, N. Piazza, H.M. Garcia-Garcia, N. Kukreja, S. Garg, J. Eindhoven, J.M. Cheng, M. Valgimigli, R. van Domburg, and P.W. Serruys Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries JACC Cardiovasc Interv 3 2010 584 594
6. M.C. Morice, P.W. Serruys, A.P. Kappetein, T.E. Feldman, E. Ståhle, A. Colombo, M.J. Mack, D.R. Holmes, L. Torracca, G.A. van Es, K. Leadley, K.D. Dawkins, and F. Mohr Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial Circulation 121 2010 2645 2653
7. A.P. Kappetein, T.E. Feldman, M.J. Mack, M.C. Morice, D.R. Holmes, E. Ståhle, K.D. Dawkins, F.W. Mohr, P.W. Serruys, and A. Colombo Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
8. S.J. Park, Y.H. Kim, D.W. Park, S.C. Yun, J.M. Ahn, H.G. Song, J.Y. Lee, W.J. Kim, S.J. Kang, S.W. Lee, C.W. Lee, S.W. Park, C.H. Chung, J.W. Lee, D.S. Lim, S.W. Rha, S.G. Lee, H.C. Gwon, H.S. Kim, I.H. Chae, Y. Jang, M.H. Jeong, S.J. Tahk, and K.B. Seung Randomized trial of stents versus bypass surgery for left main coronary artery disease N Engl J Med 364 2011 1718 1727
9. F.G. Kushner, M. Hand, S.C. Smith Jr., S.B. King III, J.L. Anderson, E.M. Antman, S.R. Bailey, E.R. Bates, J.C. Blankenship, D.E. Casey Jr., L.A. Green, J.S. Hochman, A.K. Jacobs, H.M. Krumholz, D.A. Morrison, J.P. Ornato, D.L. Pearle, E.D. Peterson, M.A. Sloan, P.L. Whitlow, and D.O. Williams 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
10. D. Planer, P.C. Smits, D.J. Kereiakes, E. Kedhi, M. Fahy, K. Xu, P.W. Serruys, and G.W. Stone Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials JACC Cardiovasc Interv 4 2011 1104 1115
11. U. Baber, R. Mehran, S.K. Sharma, S. Brar, J. Yu, J.W. Suh, H.S. Kim, S.J. Park, A. Kastrati, A. de Waha, P. Krishnan, P. Moreno, J. Sweeny, M.C. Kim, J. Suleman, R. Pyo, J. Wiley, J. Kovacic, A.S. Kini, and G.D. Dangas Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials J Am Coll Cardiol 58 2011 1569 1577
12. T. Palmerini, G. Biondi-Zoccai, D.D. Riva, C. Stettler, D. Sangiorgi, F. D'Ascenzo, T. Kimura, C. Briguori, M. Sabatè, H.S. Kim, A. De Waha, E. Kedhi, P.C. Smits, C. Kaiser, G. Sardella, A. Marullo, A.J. Kirtane, M.B. Leon, and G.W. Stone Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
13. F. Alfonso, and C. Fernandez Second-generation drug-eluting stents. Moving the field forward J Am Coll Cardiol 58 2011 26 29
14. N. Salvatella, M.C. Morice, O. Darremont, M. Tafflet, P. Garot, J.L. Leymarie, B. Chevalier, T. Lefèvre, Y. Louvard, N. Boudou, N. Dumonteil, and D. Carrié Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX pilot study Eurointervention 30 2011 689 696
15. M. Valgimigli, P. Malagutti, G.A. Rodriguez-Granillo, H.M. Garcia-Garcia, J. Polad, K. Tsuchida, E. Regar, W.J. Van der Giessen, P. de Jaegere, P. De Feyter, and P.W. Serruys Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries J Am Coll Cardiol 18 2006 1530 1537
16. M. Toyofuku, T. Kimura, T. Morimoto, Y. Hayashi, H. Ueda, K. Kawai, Y. Nozaki, S. Hiramatsu, A. Miura, Y. Yokoi, S. Toyoshima, H. Nakashima, K. Haze, M. Tanaka, S. Take, S. Saito, T. Isshiki, K. Mitsudo, and J-Cypher Registry Investigators Three-year outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease: insights from the j-Cypher registry Circulation 120 2009 1866 1874
17. D. Capodanno, G.W. Stone, M.C. Morice, T.A. Bass, and C. Tamburino Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data J Am Coll Cardiol 58 2011 1426 1432
18. J. Mehilli, A. Kastrati, R.A. Byrne, O. Bruskina, R. Iijima, S. Schulz, J. Pache, M. Seyfarth, S. Massberg, K.L. Laugwitz, J. Dirschinger, and A. Schömig Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease J Am Coll Cardiol 53 2009 1760 1768
19. M. Valgimigli, P. Malagutti, J. Aoki, H.M. Garcia-Garcia, G.A. Rodriguez Granillo, C.A. van Mieghem, J.M. Ligthart, A.T. Ong, G. Sianos, E. Regar, R.T. Van Domburg, P. De Feyter, P. de Jaegere, and P.W. Serruys Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis J Am Coll Cardiol 47 2006 507 514
20. J.Y. Lee, D.W. Park, S.C. Yun, S.W. Lee, Y.H. Kim, C.W. Lee, M.K. Hong, S.W. Park, and S.J. Park Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease. Analysis of the MAIN COMPARE registry J Am Coll Cardiol 54 2009 853 859
21. E. Meliga, H.M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A.O. Maree, N. Gonzalo, S. Cook, S. Marra, C. Moretti, S. De Servi, I.F. Palacios, S. Windecker, R. van Domburg, A. Colombo, I. Sheiban, and P.W. Serruys Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the Sirolimus vs Paclitaxel Drug-Eluting Stent for Left Main registry (SP-DELFT) Int J Cardiol 137 2009 16 21
22. E. Meliga, H.M. Garcia-Garcia, M. Valgimigli, A. Chieffo, G. Biondi-Zoccai, A.O. Maree, S. Cook, L. Reardon, C. Moretti, S. De Servi, I.F. Palacios, S. Windecker, A. Colombo, R. van Domburg, I. Sheiban, and P.W. Serruys Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting Stent for Left Main) registry J Am Coll Cardiol 51 2008 2212 2219
23. C. Godino, G. Parodi, S. Furuichi, A. Latib, R. Barbagallo, O. Goktekin, M. Cera, R. Mueller, C. Tamburino, E. Grube, C. Di Mario, B. Reimers, A. Chieffo, D. Antoniucci, A. Colombo, and G.M. Sangiorgi Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE registry) EuroIntervention 5 2010 906 916
24. J.A. Gómez-Hospital, J. Gomez-Lara, J. Rondan, S. Homs, I. Lozano Martínez-Luengas, J.L. Ferreiro, G. Roura, J. Maristany, L. Teruel, A. Carro, P. Avanzas, P. Jara, E. Esplugas, C. Moris, and A. Cequier Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery Rev Esp Cardiol 65 2012 530 537
25. A. Chieffo, S.J. Park, E. Meliga, I. Sheiban, M.S. Lee, A. Latib, Y.H. Kim, M. Valgimigli, D. Sillano, V. Magni, G. Biondi-Zoccai, M. Montorfano, F. Airoldi, R. Rogacka, M. Carlino, I. Michev, C.W. Lee, M.K. Hong, S.W. Park, C. Moretti, E. Bonizzoni, G.M. Sangiorgi, J. Tobis, P.W. Serruys, and A. Colombo Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry Eur Heart J 29 2008 2108 2115
26. G.W. Stone, E. Kedhi, D.J. Kereiakes, H. Parise, M. Fahy, P.W. Serruys, and P.C. Smits Differential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitus Circulation 124 2011 893 900
27. S.J. Park, Y.H. Kim, D.W. Park, S.W. Lee, W.J. Kim, J. Suh, S.C. Yun, C.W. Lee, M.K. Hong, J.H. Lee, S.W. Park, and MAIN-COMPARE Investigators Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis Circ Cardiovasc Interv 2 2009 167 177